I 

118TH CONGRESS 

2D SESSION H. R. 7155 

To provide for the establishment, within the Food and Drug Administration, 

of an Abraham Accords Bureau to promote and facilitate cooperation 

between the Food and Drug Administration and entities in Abraham 

Accords countries wishing to work with the agency in order to develop 

and sell products in the United States, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 31, 2024 

Mrs. HARSHBARGER (for herself, Mr. VARGAS, Mr. WEBER of Texas, Mr. 

PETERS, Mr. HARRIS, Mr. LEVIN, and Mr. ALLEN) introduced the following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To provide for the establishment, within the Food and Drug 

Administration, of an Abraham Accords Bureau to promote and facilitate cooperation between the Food and 

Drug Administration and entities in Abraham Accords 

countries wishing to work with the agency in order to 

develop and sell products in the United States, and for 

other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7155 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘United States-Abra3 ham Accords Cooperation and Security Act of 2024’’. 

4 SEC. 2. ESTABLISHMENT OF ABRAHAM ACCORDS BUREAU 

5 WITHIN FOOD AND DRUG ADMINISTRATION. 

6 (a) IN GENERAL.—Chapter X of the Federal Food, 

7 Drug, and Cosmetic Act (21 U.S.C. 391 et seq.) is amend8 ed by adding at the end the following: 

9 ‘‘SEC. 1015. ABRAHAM ACCORDS BUREAU. 

10 ‘‘(a) IN GENERAL.—The Secretary, acting through 

11 the Commissioner of Food and Drugs, shall establish with12 in the Food and Drug Administration a bureau, to be 

13 known as the Abraham Accords Bureau, to be headed by 

14 a director. 

15 ‘‘(b) OFFICES.—Not later than one year after the 

16 date of enactment of this section, the Secretary shall— 

17 ‘‘(1) in consultation with the governments of 

18 Abraham Accords countries— 

19 ‘‘(A) select the locations of one or more of20 fices of the Abraham Accords Bureau in one or 

21 more Abraham Accords countries; and 

22 ‘‘(B) establish each such office; and 

23 ‘‘(2) assign to each such office such personnel 

24 of the Food and Drug Administration as the Sec25 retary determines necessary to carry out the func26 tions of the office. 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•HR 7155 IH

1 ‘‘(c) DUTIES.—The Secretary, acting through the Di2 rector of the Abraham Accords Bureau, shall— 

3 ‘‘(1) not later than 90 days after all offices of 

4 the Abraham Accords Bureau are established— 

5 ‘‘(A) develop a list of essential medical, 

6 biomedical, and life sciences products, the key 

7 raw pharmaceutical ingredients of such prod8 ucts, and the active pharmaceutical ingredients 

9 of such products, that are primarily manufac10 tured in a covered country; 

11 ‘‘(B) develop a list of medical, biomedical, 

12 and life sciences facilities and entities in Abra13 ham Accord countries that can engage with of14 fices of the Abraham Accords Bureau to bolster 

15 the United States’ health care and medical sup16 ply needs; and 

17 ‘‘(C) submit such lists to the Congress; 

18 ‘‘(2) not less than every 3 years thereafter, up19 date the lists under paragraph (1) and submit the 

20 updated lists to the Congress; 

21 ‘‘(3) consult with parties in Abraham Accords 

22 countries on good manufacturing practices and other 

23 issues relevant to manufacturing medical products 

24 that are regulated by the Food and Drug Adminis25 tration; 


ssavage on LAPJG3WLY3PROD with BILLS
4 

•HR 7155 IH

1 ‘‘(4) facilitate interactions between the Food 

2 and Drug Administration and interested parties in 

3 Abraham Accords countries, including by sharing 

4 relevant information regarding United States regu5 latory pathways with such parties; 

6 ‘‘(5) offer technical assistance on manufac7 turing drugs and devices to interested parties in 

8 Abraham Accords countries; and 

9 ‘‘(6) carry out other functions and activities as 

10 the Secretary determines to be necessary to carry 

11 out this section. 

12 ‘‘(d) LIMITATION.—Notwithstanding any other provi13 sion of this section, this section does not authorize any 

14 assistance to any entity in an Abrahams Accords country 

15 that, for purposes of manufacturing, uses any ingredient 

16 or product that is produced or manufactured in a covered 

17 country. 

18 ‘‘(e) DEFINITIONS.—In this section: 

19 ‘‘(1) The term ‘Abraham Accords country’ 

20 means a country identified by the Department of 

21 State as having signed the Abraham Accords Dec22 laration. 

23 ‘‘(2) The term ‘covered country’ means a coun24 try— 


ssavage on LAPJG3WLY3PROD with BILLS
5 

•HR 7155 IH

1 ‘‘(A) designated as a country of particular 

2 concern for religious freedom under section 

3 402(b)(1)(A)(ii) of the International Religious 

4 Freedom Act of 1998; or 

5 ‘‘(B) the government of which engages in 

6 a consistent pattern of gross violations of inter7 nationally recognized human rights, as defined 

8 in section 502B(d)(1) of the Foreign Assistance 

9 Act of 1961. 

10 ‘‘(3) The term ‘essential medical products’ shall 

11 have such definition as the Secretary may determine 

12 for purposes of this section. 

13 ‘‘(4) The term ‘primarily manufactured in a 

14 covered country’ means— 

15 ‘‘(A) manufactured in a covered country in 

16 final form; or 

17 ‘‘(B) containing any active pharmaceutical 

18 ingredient or excipient that was manufactured 

19 in a covered country.’’. 

20 (b) REPORT TO CONGRESS.—Not later than 3 years 

21 after the date of enactment of this Act, the Secretary of 

22 Health and Human Services shall submit to the Congress 

23 a report on the Abraham Accords Bureau, including— 

24 (1) an evaluation of— 


ssavage on LAPJG3WLY3PROD with BILLS
6 

•HR 7155 IH

1 (A) how each office of the Bureau has ad2 vanced progress toward shifting United States 

3 supply chains of essential medical products 

4 from covered countries to Abraham Accords 

5 countries (as such terms are defined in section 

6 1015 of the Federal Food, Drug, and Cosmetic 

7 Act, as added by subsection (a)); and 

8 (B) the effectiveness of the activities car9 ried out pursuant to section 1015(c) of the 

10 Federal Food, Drug, and Cosmetic Act, as 

11 added by subsection (a); and 

12 (2) recommendations for increasing and improv13 ing coordination between the Food and Drug Admin14 istration and entities in Abraham Accords countries 

15 (as such term is defined in section 1015 of the Fed16 eral Food, Drug, and Cosmetic Act, as added by 

17 subsection (a)). 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS